Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Top 20 VC funds in North Africa and the Middle East that took part in the most Late Stage funding rounds in Medical Service industry over the recent years

Top 20 VC funds in North Africa and the Middle East that took part in the most Late Stage funding rounds in Medical Service industry over the recent years

Intro

Top 20 VC funds according to the total amount of funding rounds. These are active VC funds that have invested in Late Stage over the last 3 years. These funds are actively investing in Medical Service industry.

Top 20 VC funds in North Africa and the Middle East that took part in the most Late Stage funding rounds in Medical Service industry over the recent years
data provided by Unicorn Nest

Save this chart to use it in your presentation
Download the diagram

Market analysis

Amount of funding rounds in North Africa and the Middle East is 51, which is 1.7% from the total amount of Late Stage rounds in Medical Service industry.

About the top Funds:

  • The first place is taken by OurCrowd which is a Corporate Investor. The last place belongs to aMoon Fund which is a VC.
  • The most common country among top VCs is Israel which hosts 15 funds. There are also funds from Saudi Arabia, Qatar and Turkey.
  • VCs in the sample made the most deals in the period from 2007 to 2019. For some funds 2019 was the year with the most amount of deals.
  • The minimum number of portfolio companies for VCs in the sample is 2, the maximum is 251. Average number of portfolio companies is 40.3 while median is 14.0. The most common amount of portfolio companies for VCs in the sample is 2.
Late Stage Venture Medical Service North Africa and the Middle East
Looking for investments?
We help you to get a list of investors based on your personal choice
Crunchbase icon

Content report

The following text will be sent to our editors: